COM:HALOZYME
Halozyme Therapeutics, Inc.
- Stock
locale
United Statesmarket
STOCKSindustry
Biopharmaceuticalswebsite
halozyme.com/crunchbase
halozyme-therapeuticslinkedin
halozyme-therapeutics-inc-founding date
Jan 01, 1998ipo date
Mar 16, 2004
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable biologics, such as monoclonal an...Show More